FDA commissioner stands firm on mifepristone access despite pressure from pro-life groups
(NaturalNews) FDA Commissioner Marty Makary reaffirmed that the FDA has no plans to restrict mifepristone, a key abortion medication, despite pressure from...
 | (NaturalNews) FDA Commissioner Marty Makary reaffirmed that the FDA has no plans to restrict mifepristone, a key abortion medication, despite pressure from... |
